BPDZ 154 Activates Adenosine 5’-Triphosphate-Sensitive Potassium Channels; In Vitro Studies Using Rodent Insulin-Secreting Cells and Islets Isolated from Patients with Hyperinsulinism
Cosgrove, K. E.; Antoine, M.-H.; Lee, A. T.et al.
2002 • In Journal of Clinical Endocrinology and Metabolism, 87, p. 4860-4868
BPDZ 154 Activates Adenosine 5’-Triphosphate-Sensitive Potassium Channels; In Vitro Studies Using Rodent Insulin-Secreting Cells and Islets Isolated from Patients with Hyperinsulinism
Publication date :
2002
Journal title :
Journal of Clinical Endocrinology and Metabolism
ISSN :
0021-972X
eISSN :
1945-7197
Publisher :
Endocrine Society, Chevy Chase, United States - Maryland
Glaser B, Thornton PS, Otonkoski T, Junien C 2000 The genetics of neonatal hyperinsulinism. Arch Dis Child 82:79-86
Sempoux C, Guiot Y, Lefevre A, Nihoul-Fekete C, Jaubert F, Saudubray JM, Rahier J 1998 Neonatal hyperinsulinemic hypoglycemia: Heterogeneity of the syndrome and keys for differential diagnosis. J Clin Endocrinol Metab 83:1455-1461
de Lonlay-Debeney P, Poggi-Trovert F, Fournet JC, Sempoux J, Vici AD, Brunelle F, Touati G, Rahier J, Junien C, Nihoul-Fékété C, Robert JJ, Saudubray JM 1999 Clinical features of 52 neonates with hyperinsulinism. N Engl J Med 340:1169-1175
de Lonlay P, Fournet JC, Touati G, Groos MS, Martin D, Sevin C, Delagne V, Mayaud C, Chigot V, Sempoux C, Brusset MC, Laborde K, Bellane-Chantelot C, Vassault A, Rahier J, Junien C, Brunelle F, Nihoul-Fekete C, Saudubray JM, Robert JJ 2002 Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 161:37-48
de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 1997 Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycaemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 100:802-807
Verkarre V, Fournet JC, de Lonlay P, Gross-Morand MS, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 1998 Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 102:1286-1291
Fournet JC, Mayaud C, de Lonlay P, Gross-Morand MS, Verkarre V, Castanet M, Devillers M, Rahier J, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C 2001 Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozy-gosity of a mutation in ABCC8 or KCNJ11. Am J Pathol 158:2177-2184
Glaser B, Furth J, Stanley CA, Baker L, Thornton PA, Landau H, Permutt MA 1999 Intragenic single nucleotide polymorphism haplotype analysis of SUR1 mutations in familial hyperinsulinism. Hum Mutat 14:23-29
Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM, Herold KC 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med 338:226-230
Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E, Poncz M 1998 Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352-1357
Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, Datta V, Malingre HE, Berger R, van den Berg IE 2001 Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J Clin Invest 108:457-465
Kane C, Shepherd RM, Squires PE, Johnson PRV, James RFL, Milla PJ, Aynsley-Green A, Lindley KJ, Dunne MJ 1996 Loss of functional KATP channels in β-cells causes persistem hyperinsulinaemic hypoglycaemia of infancy. Nat Med 2:1344-1347
Dunne MJ, Kane C, Shepherd RM, Sanchez G, James RFL, Johnson PRV, Aynsley-Green A, Lu S, Clement JP, Lindley KJ, Seino S, Aguilar-Bryan L 1997 Familial persistent hyperinsulinemic hypoglycaemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med 336:703-706
Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fékété C, De Lonlay-Debeney P, Brunelle F, Otonkoski T, Thornton P, Lindley JK 2000 The practical management of hyperinsulinism in infancy. Arch Dis Child 82:F98-F107
Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, Czernichow P, Saudubray JM 1998 Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: A retrospective review of 77 cases and analysis of efficacy-predicting criteria. Eur J Pediatr 157:628-633
Sadeghi-Nejad A, Graeme-Cook FM 2001 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 39-2001. A newborn girl with seizures and persistent hypoglycaemia. N Engl J Med 345:1833-1839
Lebrun P, Arkhammar P, Antoine M-H, Nguyen QA, Bondo-Hansen J, Pirotte B 2000 A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release. Diabetologia 43:723-732
Boverie S, Antoine MH, de Tullio P, Somers F, Becker B, Sebille S, Lebrun P, Pirotte B 2001 Effect on insulin release of compounds structurally related to the potassium-channel opener 7-chloro-3-isopropylamino-4H-1, 2, 4-benzothiadiazine 1, 1-dioxide (BPDZ 73): Introduction of heteroatoms on the 3-alkylamino side chain of Lhe benzothiadiazme 1, 1-dioxide ring. J Pharm Pharmacol 53:973-980
Pirotte B, Antoine MH, de Tullio P, Hermann M, Herchuelz A, Delarge J, Lebrun P 1994 A pyridothiadiazine (BPDZ 44) as a new and potent activator of ATP-sensitive K+ channels. Biochem Pharmacol 47:1381-1386
Antoine MH, Pirotte B, Hermann M, de Tullio P, Delarge J, Herchuelz A, Lebrun P 1994 Cationic and secretory effects of BPDZ 44 and diazoxide in rat pancreatic islets. Experientia 50:830-832
Lebrun P, Malaisse WJ, Herchuelz A 1982 Evidence for two distinct modalities Of Ca2+ influx into pancreatic B cell. Am J Physiol 242:E56-E66
Lebrun P, Antoine M-H, Ouedraogo R, Kane C, Dunne MJ, Hermann M, Herchuelz A, Masereel B, Delarge J, de Tullio P, Pirotte B 1996 Activation of ATP-dependent K+ channels and inhibition of insulin release: Effect of BPDZ 62. J Pharmacol Exp Ther 277:156-162
Becker B, Antoine M-H, Nguyen QA, Rigo B, Cosgrove KE, Barnes PD, Dunne MJ, Pirotte B, Lebrun P 2001 Synthesis and characterization of a quinolinonic compound activating ATP-sensitive K+ channels in endocrine and smooth muscle tissues. Br J Pharmacol 134:375-385
Leclercq-Meyer V, Marchand J, Woussen-Colle M-C, Giroix M-H, Malaisse WJ 1985 Multiple effects of leucine on glucagon, insulin and somatostatin secretion from the perfused rat pancreas. Endocrinology 116:1168-1174
Straub SG, Cosgrove KE, Ämmälä C, Shepherd RM, O'Brien RE, Barnes PD, Kuchinski N, Chapman JC, Schaeppi M, Glaser B, Lindley KJ, Sharp GWG, Aynsley-Green A, Dunne MJ 2001 Hyperinsulinism of infancy; the regulated release of insulin by KATP channel-independent pathways. Diabetes 50: 329 -339
Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd RM, Giesberts AN, White SJ, Ämmälä C, Flatt PR, Dunne MJ 1999 ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 β-cell line. Diabetes 48:2349-2357
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ 1981 Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100
Dunne MJ, Illot MC, Petersen OH 1987 Interactions of diazoxide, tolbutamide and ATP4- on nucleotide-dependent K+ channels in an insulin-secreting cell line. J Membr Biol 99:215-224
De Tullio P, Pirotte B, Somers F, Boverie S, Lacan F, Delarge J 1998 Study of the ring closure reaction of o-aminoarylsulfonamides with 1, 1′-thiocarbonyldiimidazole. Tetrahedron 54:4935-4942
Raffa L, Di Bella M, Ferrari P, Rinaldi M, Ferrari W 1974 Cardiovascular effect of the 1, 2, 4-benzothia diazine-1, 1-dioxide. IV Farmaco 29:411-423
Bitner-Glindzicz M, Lindley KJ, Rutland P, Blaydon D, Smith VV, Milla PJ, Hussain K, Furth-Lavi J, Cosgrove KE, Shepherd RM, Barnes PD, O'Brien RE, Farndon PA, Liu X, Sowden J, Malcolm S, Dunne MJ, Aynsley-Green A, Glaser B 2000 A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher Type 1C gene. Nat Genet 26:56-60
Lawson K, Dunne MJ 2001 Peripheral channelopathies as targets for potassium channel openers. Expert Opin Investig Drugs 10:1345-1359
Cosgrove KE, Barnes PD, O'Brien RE, Rahier J, Fournet J-C, Junien C, Nihoul-Fekete C, Swift SM, Lindley KJ, Glaser B, Saudubray J-M, Aynsley-Green A, Dunne MJ 2001 Typing hyperinsulinism of infancy from a cohort of 68 patients. Pediatr Res 49:44A
Otonkoski T, Ammälä C, Huopio H, Cote GJ, Chapman JC, Cosgrove KE, Ashfield R, Huang E, Komulainen J, Ashcroft FM, Dunne MJ, Kere J, Thomas PM 1999 A point mutation inactivating Lhe sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycaemia of infancy in Finland. Diabetes 48:408-415
Cartier EA, Conti LR, Vandenberg CA, Shyng S-L 2001 Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycaemia of infancy. Proc Natl Acad Sci USA 98:2882-2887
Zucker LM, Antoniades HN 1972 Insulin and obesity in the Zucker genetically obese rat "fatty." Endocrinology 90:1320-1330
Alemzadeh R., Slonim AE, Zadnowicz MM, Maturo J 1993 Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology 133:705-712
Alemzadeh R, Jacobs W, Pitukcheewanont P 1996 Anti-obesity effect of diazoxide in obese Zucker rats. Metabolism 45:334-351
Hensley IE, Lawler JE, Alemzadeh R, Holshouser SJ 2001 Diazoxide effects on hypothalamic and extra-hypothalamic NPY content in Zucker rats. Peptides 22:899-908
Rasmussen SB, Sorensen TS, Hansen JB, Mandrup-Poulsen T, Hornum L, Markholst H 2000 Functional rest through intensive treatment with insulto and potassium channel openers preserves residual β-cell function and mass in acutely diabetic BB rats. Horm Metab Res 32:294-300
Greenwood RH, Mahler RF, Hales CN 1976 Improvement in insulin secretion in diabetes after diazoxide. Lancet 1:444-447
Bjork E, Berne C, Kampe O, Wibell L, Oskarsson P, Karlsson FA 1996 Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes. Diabetes 45:1427-1430
Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE 1998 Beneficiai effect of diazoxide in obese hyperinsulinernic adults. J Clin Endocrinal Metab 83:1911-1915
Leahy JL, Bumbalo LM, Chen C 1994 Diazoxide causes recovery of β-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes 43: 173-179
